BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17953998)

  • 1. Incidence and predictors of abnormal fasting plasma glucose among the university hospital employees in Thailand.
    Jiamjarasrangsi W; Lohsoonthorn V; Lertmaharit S; Sangwatanaroj S
    Diabetes Res Clin Pract; 2008 Feb; 79(2):343-9. PubMed ID: 17953998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased alanine aminotransferase level and future risk of type 2 diabetes and impaired fasting glucose among the employees in a university hospital in Thailand.
    Jiamjarasrangsi W; Sangwatanaroj S; Lohsoonthorn V; Lertmaharit S
    Diabetes Metab; 2008 Jun; 34(3):283-9. PubMed ID: 18486512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes, impaired fasting glucose, and their association with increased hepatic enzyme levels among the employees in a university hospital in Thailand.
    Jiamjarasrangsi W; Lertmaharit S; Sangwatanaroj S; Lohsoonthorn V
    J Med Assoc Thai; 2009 Jul; 92(7):961-8. PubMed ID: 19626817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of type 2 diabetes among professional and office workers in Bangkok, Thailand.
    Jiamjarasrangsi W; Aekplakorn W
    J Med Assoc Thai; 2005 Dec; 88(12):1896-904. PubMed ID: 16518992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
    Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
    J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired fasting glycaemia and undiagnosed diabetes: prevalence, cardiovascular and behavioural risk factors.
    Lecomte P; Vol S; Cacès E; Lasfargues G; Combe H; Laurent S; Tichet J
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):311-20. PubMed ID: 12442069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000.
    Forouhi NG; Luan J; Hennings S; Wareham NJ
    Diabet Med; 2007 Feb; 24(2):200-7. PubMed ID: 17257284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius.
    Söderberg S; Zimmet P; Tuomilehto J; de Courten M; Dowse GK; Chitson P; Stenlund H; Gareeboo H; Alberti KG; Shaw J
    J Intern Med; 2004 Jul; 256(1):37-47. PubMed ID: 15189364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study.
    Magliano DJ; Barr EL; Zimmet PZ; Cameron AJ; Dunstan DW; Colagiuri S; Jolley D; Owen N; Phillips P; Tapp RJ; Welborn TA; Shaw JE
    Diabetes Care; 2008 Feb; 31(2):267-72. PubMed ID: 17989310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of type 2 diabetes mellitus and impaired fasting glucose in semi-urban population of Nepal.
    Ono K; Limbu YR; Rai SK; Kurokawa M; Yanagida J; Rai G; Gurung N; Sharma M; Rai CK
    Nepal Med Coll J; 2007 Sep; 9(3):154-6. PubMed ID: 18092429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
    Nichols GA; Hillier TA; Brown JB
    Am J Med; 2008 Jun; 121(6):519-24. PubMed ID: 18501234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
    Alvarsson M; Hilding A; Ostenson CG
    Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study.
    Vambergue A; Dognin C; Boulogne A; Réjou MC; Biausque S; Fontaine P
    Diabet Med; 2008 Jan; 25(1):58-64. PubMed ID: 18028442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.
    Vaidya D; Kelemen MD; Bittner V; Tardif JC; Thompson P; Ouyang P
    J Womens Health (Larchmt); 2007 Mar; 16(2):228-34. PubMed ID: 17388739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.